Stock ScreenerStock IdeasBiotech BreakthroughsBest Biotech Stocks To Buy NowTop biotech stocks that analysts expect to be profitable within the next 3 years
Stock ScreenerStock IdeasBiotech Breakthroughs
Industry: Biotechnology
Forecast Earnings Growth: Positive
| Ticker | Company | Zen Rating | Price | Value | Graham Fair Value | Graham Fair Value % | P/E | Forward P/E | P/S | P/B | PEG | Free Cash Flow | Free Cash Flow Yield | Book Value | BVPS | EV | EV/EBITDA |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ONC | BEONE MEDICINES LTD | $306.05 | $7.13 | 4,194.59% | 6,121.00x | 215.36x | 6.78x | 8.21x | 16.49x | $529.27M | 1.57% | $4.13B | 37.48 | $31.77B | 99.89 | ||
| CORT | CORCEPT THERAPEUTICS INC | $82.28 | $29.52 | 178.69% | 82.28x | 80.51x | 11.49x | 13.70x | 1.28x | $162.57M | 1.91% | $631.90M | 6.10 | $8.54B | 129.38 | ||
| NVO | NOVO NORDISK A S | $47.77 | $142.57 | -66.49% | 13.28x | 2.00x | 4.36x | 8.11x | 0.14x | $9.34B | 4.40% | $26.18B | 5.89 | $222.92B | 8.98 | ||
| ALNY | ALNYLAM PHARMACEUTICALS INC | $392.10 | $29.63 | 1,223.27% | 1,264.84x | 209.43x | 16.06x | 221.48x | 5.19x | $221.36M | 0.43% | $233.89M | 1.78 | $53.52B | 352.31 | ||
| ZVRA | ZEVRA THERAPEUTICS INC | $8.11 | $11.71 | -30.75% | 16.90x | 6.21x | 5.38x | 3.43x | 0.33x | -$23.64M | -5.22% | $133.17M | 2.38 | $464.85M | 6.92 | ||
| KNSA | KINIKSA PHARMACEUTICALS INTERNATIONAL PLC | $41.47 | $14.90 | 178.32% | 84.63x | 41.56x | 5.18x | 5.87x | 1.27x | $101.73M | 3.28% | $535.38M | 7.17 | $2.98B | 55.59 | ||
| GMAB | GENMAB A | $31.71 | $108.86 | -70.87% | 13.53x | 1.76x | 5.71x | 3.54x | 0.12x | $1.19B | 5.87% | $5.75B | 8.96 | $18.74B | 9.37 | ||
| ARGX | ARGENX SE | $862.05 | $278.03 | 210.06% | 34.45x | 47.92x | 27,808.06x | 7.34x | 2.38x | $467.72M | 0.89% | $7.17B | 117.50 | $50.21B | 61.89 | ||
| LGND | LIGAND PHARMACEUTICALS INC | $194.59 | $64.99 | 199.43% | 84.24x | 25.24x | 15.16x | 4.03x | 1.39x | $30.76M | 0.81% | $950.17M | 48.53 | $4.14B | 40.20 | ||
| VCEL | VERICEL CORP | $36.40 | $6.66 | 446.88% | 140.00x | 132.80x | 7.10x | 5.72x | 2.60x | $20.38M | 1.11% | $321.86M | 6.38 | $1.84B | 62.72 | ||
| TECH | BIO-TECHNE CORP | $56.99 | $16.41 | 247.33% | 113.98x | 28.19x | 7.28x | 4.52x | 1.55x | $224.06M | 2.53% | $1.97B | 12.65 | $9.13B | 41.33 | ||
| RPRX | ROYALTY PHARMA PLC | $38.31 | $42.45 | -9.75% | 21.77x | 7.96x | 7.04x | 2.30x | 0.44x | $2.11B | 12.76% | $9.62B | 22.28 | $30.12B | 28.85 | ||
| KRYS | KRYSTAL BIOTECH INC | $235.80 | $67.84 | 247.60% | 34.17x | 37.74x | 18.29x | 6.01x | 3.11x | $166.02M | 2.43% | $1.14B | 39.30 | $6.45B | 33.39 | ||
| VCYT | VERACYTE INC | $42.21 | $9.24 | 356.62% | 108.23x | 80.61x | 6.71x | 2.65x | 2.22x | $98.21M | 2.96% | $1.26B | 15.98 | $3.06B | 53.69 | ||
| CRMD | CORMEDIX INC | $11.45 | $13.27 | -13.74% | 5.04x | 4.58x | 4.06x | 2.41x | 26.24x | $74.42M | 8.56% | $374.13M | 4.93 | $1.00B | 8.93 | ||
| AUPH | AURINIA PHARMACEUTICALS INC | $15.79 | $7.76 | 103.47% | 27.22x | 20.81x | 7.83x | 5.69x | 1.32x | $119.87M | 5.76% | $365.77M | 2.78 | $2.09B | 20.16 | ||
| BMRN | BIOMARIN PHARMACEUTICAL INC | $51.80 | $41.96 | 23.46% | 19.04x | 17.51x | 3.21x | 1.64x | 0.73x | $832.13M | 8.36% | $6.06B | 31.54 | $9.30B | 12.03 | ||
| HALO | HALOZYME THERAPEUTICS INC | $65.77 | $75.34 | -12.71% | 13.45x | 10.28x | 6.20x | 15.35x | 0.51x | $602.40M | 7.81% | $503.92M | 4.30 | $8.83B | 10.44 | ||
| PLX | PROTALIX BIOTHERAPEUTICS INC | $1.76 | $1.30 | 34.91% | 25.14x | 69.57x | 2.26x | 2.68x | 0.72x | -$11.69M | -8.35% | $52.91M | 0.67 | $136.07M | 15.34 | ||
| GYRE | GYRE THERAPEUTICS INC | $7.41 | $0.76 | 880.59% | 105.86x | 48.43x | 6.27x | 7.00x | 7.77x | $3.05M | 0.46% | $101.92M | 1.12 | $674.59M | 50.99 | ||
| EXEL | EXELIXIS INC | $42.00 | $29.25 | 43.57% | 17.07x | 16.24x | 4.93x | 5.21x | 1.03x | $779.77M | 6.92% | $2.16B | 8.05 | $11.06B | 11.92 | ||
| HRMY | HARMONY BIOSCIENCES HOLDINGS INC | $38.78 | $36.92 | 5.03% | 12.01x | 11.90x | 2.70x | 2.67x | 0.78x | $296.89M | 13.30% | $835.12M | 14.51 | $1.76B | 6.51 | ||
| MNKD | MANNKIND CORP | $5.97 | $1.44 | 315.21% | 59.70x | 75.00x | 5.84x | -41.15x | 2.56x | $43.39M | 2.36% | -$44.55M | -0.15 | $2.07B | 28.23 | ||
| INCY | INCYTE CORP | $97.63 | $68.12 | 43.33% | 16.16x | 13.99x | 3.97x | 4.12x | 1.08x | $1.20B | 6.27% | $4.65B | 23.77 | $16.75B | 9.95 | ||
| INVA | INNOVIVA INC | $20.05 | $15.41 | 30.12% | 10.61x | 9.36x | 3.56x | 1.48x | 1.64x | $196.54M | 14.19% | $1.01B | 14.63 | $1.28B | 5.96 | ||
| VRTX | VERTEX PHARMACEUTICALS INC | $449.52 | $170.17 | 164.16% | 31.41x | 24.06x | 9.80x | 6.59x | 1.89x | $3.34B | 2.90% | $17.32B | 67.76 | $110.95B | 23.80 | ||
| ADMA | ADMA BIOLOGICS INC | $18.83 | $9.37 | 100.90% | 21.40x | 31.47x | 9.19x | 10.39x | 1.62x | $40.73M | 0.91% | $431.19M | 1.81 | $4.49B | 26.11 | ||
| NAGE | NIAGEN BIOSCIENCE INC | $6.29 | $3.33 | 89.00% | 23.30x | 33.89x | 4.02x | 7.10x | 1.31x | $21.15M | 4.21% | $70.68M | 0.89 | $440.75M | 19.42 | ||
| UTHR | UNITED THERAPEUTICS CORP | $510.94 | $200.41 | 154.95% | 17.94x | 18.51x | 7.15x | 3.34x | 5.25x | $1.12B | 5.01% | $6.59B | 150.46 | $20.66B | 11.65 | ||
| CPRX | CATALYST PHARMACEUTICALS INC | $24.00 | $12.72 | 88.65% | 13.41x | 15.28x | 5.09x | 3.21x | 3.71x | $234.54M | 7.97% | $920.25M | 7.51 | $2.26B | 6.99 | ||
| REGN | REGENERON PHARMACEUTICALS INC | $749.79 | $359.23 | 108.72% | 17.26x | 17.06x | 5.45x | 2.55x | 2.55x | $4.22B | 5.43% | $30.96B | 298.82 | $79.00B | 13.83 | ||
| MDXG | MIMEDX GROUP INC | $7.09 | $2.78 | 155.09% | 25.32x | 16.55x | 2.67x | 4.39x | 2.25x | $66.82M | 6.36% | $238.95M | 1.61 | $926.18M | 13.38 |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.